Product
HydroLenz
1 clinical trial
1 indication
Indication
Pars Plana VitrectomyClinical trial
Safety and Preliminary Efficacy of Two Dose Levels of HydroLenz as a Protectant for Vitrectomy-Induced Lens Opacities in Subjects Undergoing VitrectomyStatus: Not yet recruiting, Estimated PCD: 2025-01-01